Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cysteamine
Drug ID BADD_D00556
Description Cystinosis is a rare disease caused by mutations in the CTNS gene that encodes for cystinosin, a protein responsible for transporting cystine out of the cell lysosome. A defect in cystinosin function is followed by cystine accumulation throughout the body, especially the eyes and kidneys.[A218721] Several preparations of cysteamine exist for the treatment of cystinosis manifestations, some in capsule form, and others in ophthalmic solution form.[L15606,L15616] In particular, cystine deposits on the eye can cause significant discomfort throughout the day and require frequent treatment with eye drops, typically every waking hour.[L15611] On August 25th 2020, the first ophthalmic solution for cystinosis requiring only 4 daily treatments was granted FDA approval.[L15606] Cysteamine eye drops are a practical and effective option for those affected by ocular cystinosis. Marketed by Recordati Rare Diseases Inc., CYSTADROPS® reduce the burden of multiple frequent medications normally administered to those with cystinosis.[L15601]
Indications and Usage Not Available
Marketing Status Prescription
ATC Code A16AA04; S01XA21
DrugBank ID DB00847
KEGG ID D03634
MeSH ID D003543
PubChem ID 6058
TTD Drug ID D0V0LB
NDC Product Code Not Available
Synonyms Cysteamine | beta-Mercaptoethylamine | beta Mercaptoethylamine | Mercaptoethylamine | Mercamine | Mercaptamine | 2-Aminoethanethiol | 2 Aminoethanethiol | Cysteinamine | Cystagon | Cysteamine Bitartrate | Bitartrate, Cysteamine | Cysteamine Tartrate (1:1) | Cysteamine Tartrate | Tartrate, Cysteamine | Cysteamine Dihydrochloride | Dihydrochloride, Cysteamine | Cysteamine Hydrochloride | Hydrochloride, Cysteamine | Cysteamine Maleate (1:1) | Cysteamine Tosylate | Tosylate, Cysteamine | Cysteamine, 35S-Labeled | 35S-Labeled Cysteamine | Cysteamine, 35S Labeled | Becaptan | Cysteamine Hydrobromide | Hydrobromide, Cysteamine
Chemical Information
Molecular Formula C2H7NS
CAS Registry Number 60-23-1
SMILES C(CS)N
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tubulointerstitial nephritis20.05.02.002--Not Available
Osteopenia15.02.03.003; 14.04.04.004--Not Available
Lymphatic disorder01.09.01.003--Not Available
Affect lability19.04.01.001--Not Available
Pre-existing disease08.01.03.0590.000249%Not Available
Gastrointestinal ulcer haemorrhage24.07.02.023; 07.04.04.006--Not Available
Urine odour abnormal20.02.01.020--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Connective tissue disorder15.06.01.006--Not Available
Malnutrition14.03.02.004--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.028--
Gastrointestinal ulcer07.04.04.002--Not Available
Blood disorder01.05.01.004--Not Available
Bone lesion15.02.04.016--Not Available
Disease progression08.01.03.0380.000249%
Psychotic disorder19.03.01.0020.000954%
Knee deformity15.10.03.002--Not Available
Renal impairment20.01.03.0100.000954%Not Available
Joint hyperextension12.04.03.004; 15.01.08.003--Not Available
Amino acid level increased13.09.01.0170.002385%Not Available
The 4th Page    First    Pre   4    Total 4 Pages